EKF Diagnostics Holdings PLC Result of AGM and Voting Results (7560Z)

TIDMEKF

RNS Number : 7560Z

EKF Diagnostics Holdings PLC

17 May 2023

EKF Diagnostics Holdings plc

("EKF" or the "Company")

Result of AGM and Voting Results

EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed global diagnostics business, a nnounces that at it's Annual General Meeting ("AGM") held earlier today, all resolutions were duly passed.

The voting results of the AGM were as follows:

 
                       For                       Against                     Withheld 
 Resolution      Votes         %              Votes              %            Votes 
             ------------  --------  -----------------------  ------  --------------------- 
 1            299,140,487   99.99%                    25,430   0.01%                 12,000 
             ------------  --------  -----------------------  ------  --------------------- 
 2            299,164,209   100.00%                    1,708   0.00%                 12,000 
             ------------  --------  -----------------------  ------  --------------------- 
 3            296,684,235   99.17%                 2,481,682   0.83%                 12,000 
             ------------  --------  -----------------------  ------  --------------------- 
 4            277,821,196   92.87%                21,344,721   7.13%                 12,000 
             ------------  --------  -----------------------  ------  --------------------- 
 5            299,127,062   99.99%                    38,855   0.01%                 12,000 
             ------------  --------  -----------------------  ------  --------------------- 
 6            298,964,519   99.95%                   158,855   0.05%                 54,543 
             ------------  --------  -----------------------  ------  --------------------- 
 7            283,417,147   94.75%                15,704,227   5.25%                 56,543 
             ------------  --------  -----------------------  ------  --------------------- 
 8            239,170,516   93.84%                15,704,227   6.16%           44,303,174 
             ------------  --------  -----------------------  ------  --------------------- 
 9            242,369,025   99.97%                    72,261   0.03%           56,736,631 
             ------------  --------  -----------------------  ------  --------------------- 
 10           290,020,135   96.94%                 9,145,782   3.06%                 12,000 
             ------------  --------  -----------------------  ------  --------------------- 
 
 
EKF Diagnostics Holdings plc                                  www.ekfdiagnostics.com 
Julian Baines, Executive Chair / Marc                       Tel: [phone] 
 Davies, CFO 
 
Singer Capital Markets (Nominated Adviser &                 Tel: [phone] 
 Broker) 
Aubrey Powell / George Tzimas / Oliver 
 Platts 
 
Walbrook PR Limited                   Tel: [phone] or [e-mail] 
Paul McManus / Lianne Applegarth          Mob: [phone] 
                                                                                 303 
 
 

About EKF Diagnostics Holdings plc ( www.ekfdiagnostics.com )

EKF is an AIM-listed global diagnostics business focussed on:

-- Point-of-Care analysers in the key areas of Hematology and Diabetes, as well as Central Laboratory products including clinical chemistry reagents, analysers and centrifuges

-- Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic food and industrial applications, as well as other higher value Contract Manufacturing services

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGNKOBQKBKDOPD

(END) Dow Jones Newswires

May 17, 2023 06:50 ET (10:50 GMT)